BSc Bioprocessing of New Medicines (Business and Management)
About this course
BSc in Bioprocessing of New Medicines (Business and Management), a chemical engineering and business and management degree centred on commercial and technical aspects of healthcare. Core topics include Statistics, Research Methods, Project Management, Accounting, and Entrepreneurship. Students complete a research project in the final year. The first year covers foundational concepts through Introduction to Biochemical Engineering Processing and Design, Biochemistry and Molecular Biology, Accounting for Business, and Understanding Management. The second year focuses on scaling and regulation with Downstream Processing, Commercialisation of Research Ideas, Law for Managers, and Strategic Human Resource Management. The final year involves advanced applications via Bioprocess Design Study, Vaccine Bioprocessing, Business Planning in Bioprocessing and Life Sciences, and Project Management for Engineers, alongside a supervised research project.
Written by AI from the university's course page and module list. It can get details wrong, so check the official course page before you rely on it.
Entry requirements
A level: AAA (Biology or Chemistry or Physics and two other subjects) IB: 38 points (A total of 18 points in three higher level subjects including grade 6 in one from Biology, Chemistry or Physics, with no higher level score below 5.)
See the highest paying Engineering degrees in the UK →
See the highest paying Business & Accounting degrees in the UK →
Admissions (2022 entry, home applicants)
Offer rate 81%: 22 offers from 27 applications, from the university's Freedom of Information return.
What students say
Based on about 48 final-year students who answered, across similar courses at this university
- Teaching on my course: 86%
- Learning opportunities: 87%
- Assessment and feedback: 81%
- Academic support: 91%
- Organisation and management: 86%
- Learning resources: 95%
- Student voice: 82%
Do students stay on the course?
Based on about 20 students who started (a small group: a rough guide only)
- Continued on course: 100%
What graduates do next
Based on about 18 graduates who answered, across similar courses at this university (a small group: a rough guide only)
- Working: 75%
- Working and studying: 5%
- Further study: 10%
- Unemployed: 5%
Most common jobs
- Engineering professionals: 30%
- Information Technology Professionals: 15%
- Managers, directors and senior officials: 10%
- Business and public service associate professionals: 10%
- Business, Research and Administrative Professionals: 10%
- Find their work meaningful: 65%
- Feel on track for their future plans: 70%
- Use what they learnt on the course: 70%
Where graduates work (5 years on)
Based on about 40 graduates, across similar courses at this university
- East Midlands: 5%
- East of England: 15%
- London: 65%
- South East: 5%
- South West: 5%
Who gets in
Based on about 25 students who started (a small group: a rough guide only)
- A levels: 65%
- Baccalaureate: 25%
- A degree: 5%
- Other HE qualification: 5%
- Other qualifications: 5%
Accreditation & quality ratings
TEF 2023 (whole university): Silver overall, Silver for student experience, Gold for student outcomes.
Modules
- Introduction to Biochemical Engineering Processing and Design
- Introduction to Biochemical Engineering
- Biochemistry and Molecular Biology
- Communication and Behaviour in Organisations
- Accounting for Business
- Understanding Management
- Introductory Statistical Methods and Computing
- Downstream Processing
- Commercialisation of Research Ideas
- Cell Production Growth
- Manufacturing Regenerative Medicines: from Lab Bench to Industry
- Law for Managers
- Strategic Human Resource Management
- Bioprocess Design Study
- Vaccine Bioprocessing
- Advanced Enterprise Implementation
- Business Planning in Bioprocessing and Life Sciences
- Research Project in Bioprocessing
- Project Management for Engineers
Questions about this course
How much do graduates of BSc Bioprocessing of New Medicines (Business and Management) at University College London earn?
The median salary is £39,000 after 15 months, £38,000 after 3 years, £58,000 after 5 years. After five years the middle half of graduates earn between £45,000 and £76,500. The £58,000 median after five years is £15,500 more than the UK median for Chemical, process and energy engineering.
What do graduates of BSc Bioprocessing of New Medicines (Business and Management) at University College London do next?
90% were in work or further study 15 months after finishing (Graduate Outcomes 2023-24).
Are students happy with the teaching on BSc Bioprocessing of New Medicines (Business and Management) at University College London?
86% of final-year students were positive about the teaching in the National Student Survey 2025-26.
What grades do I need for BSc Bioprocessing of New Medicines (Business and Management) at University College London?
The typical offer is AAA at A level, or 38 points in the IB. The average entrant had 196 UCAS points.
What is the offer rate for BSc Bioprocessing of New Medicines (Business and Management) at University College London?
81% of home applicants received an offer for 2022 entry: 22 offers from 27 applications, according to the university's Freedom of Information return.
How many students continue on BSc Bioprocessing of New Medicines (Business and Management) at University College London?
100% of students continued into their second year, and 0% left higher education.